When companies and health centres have to invest in R&D&i, they need the certainty that the Tax Agency will not object to the tax benefits that they intend to apply before making the appropriate investments.
The Royal Decree 1432/2003 regulates the issuance by the Ministry of Science and Technology of reasoned reports regarding the fulfilment of scientific and technological requirements for the application and interpretation of tax deductions for research, development and technological innovation activities, establishing the regulatory framework.
Reasoned reports are not mandatory to access tax deductions. Still, they offer companies legal certainty that the Tax Agency will not question the nature of R&D or technological innovation of the projects presented. For this, they must be certified according to the UNE 166001 standard.
The UNE 166001 standard is a guide for the correct management of R&D&i projects. It also makes it possible to identify those projects that can be considered as R&D&i. Finally, it allows the organisation to obtain better public tenders scores (General of the State, Autonomous and local).
The UNE 166001 standard is specially designed for its application in SMEs and the planning of R&D&i projects.
But how does the company identify R&D&i projects? A project is considered R&D&i when the company allocates its resources and means to:
The functions of OAK in this area are, together with the staff of the organisation:
The certificates issued by the certification authority can be:
Technical report certified by an accredited body that ensures the tax benefits determined in current legislation.
Technical report certified by an accredited body that ensures the tax benefits determined in current legislation.